Cargando…

Expression and Function of the Endocannabinoid Modulating Enzymes Fatty Acid Amide Hydrolase and N-Acylphosphatidylethanolamine-Specific Phospholipase D in Endometrial Carcinoma

Background: The concentrations of three N-acylethanolamines (NAEs), anandamide (AEA), N-oleoylethanolamide (OEA), and N-palmitylethanolamide (PEA) are increased in the endometria of women with endometrial cancer (EC). It is widely accepted that plasma levels of these three NAEs are regulated by the...

Descripción completa

Detalles Bibliográficos
Autores principales: Ayakannu, Thangesweran, Taylor, Anthony H., Bari, Monica, Mastrangelo, Nicoletta, Maccarrone, Mauro, Konje, Justin C.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2019
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6930916/
https://www.ncbi.nlm.nih.gov/pubmed/31921630
http://dx.doi.org/10.3389/fonc.2019.01363
_version_ 1783483002026721280
author Ayakannu, Thangesweran
Taylor, Anthony H.
Bari, Monica
Mastrangelo, Nicoletta
Maccarrone, Mauro
Konje, Justin C.
author_facet Ayakannu, Thangesweran
Taylor, Anthony H.
Bari, Monica
Mastrangelo, Nicoletta
Maccarrone, Mauro
Konje, Justin C.
author_sort Ayakannu, Thangesweran
collection PubMed
description Background: The concentrations of three N-acylethanolamines (NAEs), anandamide (AEA), N-oleoylethanolamide (OEA), and N-palmitylethanolamide (PEA) are increased in the endometria of women with endometrial cancer (EC). It is widely accepted that plasma levels of these three NAEs are regulated by the actions of the rate-limiting enzymes N-acylphoshatidylethanolamine-specific phospholipase D (NAPE-PLD) and fatty acid amide hydrolase (FAAH), which are synthesizing and degradative, respectively. The expression and activity of these enzymes have not previously been studied in EC. Methods: FAAH activity in peripheral blood lymphocytes, and transcript and protein expression for FAAH and NAPE-PLD in EC tissues were measured using enzyme, quantitative RT-PCR, and histomorphometry (of immunoreactive tissue sections), respectively. Samples were from 6 post-menopausal women with atrophic endometria (controls) and 34 women with histologically diagnosed EC. Concentrations of the three NAEs also measured in plasma and tissues were correlated with lymphocytic FAAH activity and the NAPE-PLD and FAAH transcript and protein levels. Results: Peripheral lymphocyte FAAH activity was unaffected in women with EC compared to controls. The FAAH transcript expression level was significantly (p < 0.0001) 75% lower in EC whilst NAPE-PLD levels were not significantly (p = 0.798) increased. In line with the transcript data, a significant (p < 0.0001) tumor type-dependent 70–90% decrease in FAAH protein and significant 4- to 14-fold increase in NAPE-PLD protein (p < 0.0001) was observed in the malignant tissue with more advanced disease having lower FAAH and higher NAPE-PLD expression than less advanced disease. Correlation analyses also confirmed that tissue NAE concentrations were inversely related to FAAH expression and directly correlated to NAPE-PLD expression and the NAPE-PLD/FAAH ratio. Conclusion: These data support our previous observation of tissue levels of AEA, OEA, and PEA and a role for NAE metabolism in the pathogenesis of EC.
format Online
Article
Text
id pubmed-6930916
institution National Center for Biotechnology Information
language English
publishDate 2019
publisher Frontiers Media S.A.
record_format MEDLINE/PubMed
spelling pubmed-69309162020-01-09 Expression and Function of the Endocannabinoid Modulating Enzymes Fatty Acid Amide Hydrolase and N-Acylphosphatidylethanolamine-Specific Phospholipase D in Endometrial Carcinoma Ayakannu, Thangesweran Taylor, Anthony H. Bari, Monica Mastrangelo, Nicoletta Maccarrone, Mauro Konje, Justin C. Front Oncol Oncology Background: The concentrations of three N-acylethanolamines (NAEs), anandamide (AEA), N-oleoylethanolamide (OEA), and N-palmitylethanolamide (PEA) are increased in the endometria of women with endometrial cancer (EC). It is widely accepted that plasma levels of these three NAEs are regulated by the actions of the rate-limiting enzymes N-acylphoshatidylethanolamine-specific phospholipase D (NAPE-PLD) and fatty acid amide hydrolase (FAAH), which are synthesizing and degradative, respectively. The expression and activity of these enzymes have not previously been studied in EC. Methods: FAAH activity in peripheral blood lymphocytes, and transcript and protein expression for FAAH and NAPE-PLD in EC tissues were measured using enzyme, quantitative RT-PCR, and histomorphometry (of immunoreactive tissue sections), respectively. Samples were from 6 post-menopausal women with atrophic endometria (controls) and 34 women with histologically diagnosed EC. Concentrations of the three NAEs also measured in plasma and tissues were correlated with lymphocytic FAAH activity and the NAPE-PLD and FAAH transcript and protein levels. Results: Peripheral lymphocyte FAAH activity was unaffected in women with EC compared to controls. The FAAH transcript expression level was significantly (p < 0.0001) 75% lower in EC whilst NAPE-PLD levels were not significantly (p = 0.798) increased. In line with the transcript data, a significant (p < 0.0001) tumor type-dependent 70–90% decrease in FAAH protein and significant 4- to 14-fold increase in NAPE-PLD protein (p < 0.0001) was observed in the malignant tissue with more advanced disease having lower FAAH and higher NAPE-PLD expression than less advanced disease. Correlation analyses also confirmed that tissue NAE concentrations were inversely related to FAAH expression and directly correlated to NAPE-PLD expression and the NAPE-PLD/FAAH ratio. Conclusion: These data support our previous observation of tissue levels of AEA, OEA, and PEA and a role for NAE metabolism in the pathogenesis of EC. Frontiers Media S.A. 2019-12-19 /pmc/articles/PMC6930916/ /pubmed/31921630 http://dx.doi.org/10.3389/fonc.2019.01363 Text en Copyright © 2019 Ayakannu, Taylor, Bari, Mastrangelo, Maccarrone and Konje. http://creativecommons.org/licenses/by/4.0/ This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
spellingShingle Oncology
Ayakannu, Thangesweran
Taylor, Anthony H.
Bari, Monica
Mastrangelo, Nicoletta
Maccarrone, Mauro
Konje, Justin C.
Expression and Function of the Endocannabinoid Modulating Enzymes Fatty Acid Amide Hydrolase and N-Acylphosphatidylethanolamine-Specific Phospholipase D in Endometrial Carcinoma
title Expression and Function of the Endocannabinoid Modulating Enzymes Fatty Acid Amide Hydrolase and N-Acylphosphatidylethanolamine-Specific Phospholipase D in Endometrial Carcinoma
title_full Expression and Function of the Endocannabinoid Modulating Enzymes Fatty Acid Amide Hydrolase and N-Acylphosphatidylethanolamine-Specific Phospholipase D in Endometrial Carcinoma
title_fullStr Expression and Function of the Endocannabinoid Modulating Enzymes Fatty Acid Amide Hydrolase and N-Acylphosphatidylethanolamine-Specific Phospholipase D in Endometrial Carcinoma
title_full_unstemmed Expression and Function of the Endocannabinoid Modulating Enzymes Fatty Acid Amide Hydrolase and N-Acylphosphatidylethanolamine-Specific Phospholipase D in Endometrial Carcinoma
title_short Expression and Function of the Endocannabinoid Modulating Enzymes Fatty Acid Amide Hydrolase and N-Acylphosphatidylethanolamine-Specific Phospholipase D in Endometrial Carcinoma
title_sort expression and function of the endocannabinoid modulating enzymes fatty acid amide hydrolase and n-acylphosphatidylethanolamine-specific phospholipase d in endometrial carcinoma
topic Oncology
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6930916/
https://www.ncbi.nlm.nih.gov/pubmed/31921630
http://dx.doi.org/10.3389/fonc.2019.01363
work_keys_str_mv AT ayakannuthangesweran expressionandfunctionoftheendocannabinoidmodulatingenzymesfattyacidamidehydrolaseandnacylphosphatidylethanolaminespecificphospholipasedinendometrialcarcinoma
AT tayloranthonyh expressionandfunctionoftheendocannabinoidmodulatingenzymesfattyacidamidehydrolaseandnacylphosphatidylethanolaminespecificphospholipasedinendometrialcarcinoma
AT barimonica expressionandfunctionoftheendocannabinoidmodulatingenzymesfattyacidamidehydrolaseandnacylphosphatidylethanolaminespecificphospholipasedinendometrialcarcinoma
AT mastrangelonicoletta expressionandfunctionoftheendocannabinoidmodulatingenzymesfattyacidamidehydrolaseandnacylphosphatidylethanolaminespecificphospholipasedinendometrialcarcinoma
AT maccarronemauro expressionandfunctionoftheendocannabinoidmodulatingenzymesfattyacidamidehydrolaseandnacylphosphatidylethanolaminespecificphospholipasedinendometrialcarcinoma
AT konjejustinc expressionandfunctionoftheendocannabinoidmodulatingenzymesfattyacidamidehydrolaseandnacylphosphatidylethanolaminespecificphospholipasedinendometrialcarcinoma